TXTM (ProText Mobility) Gross Margin %: 0.00% (As of Sep. 2014)


What is ProText Mobility Gross Margin %?

ProText Mobility TXTM Gross Margin % is 0.00% as of Sep. 2014.

Gross Margin % is calculated as gross profit divided by its revenue. ProText Mobility's Gross Profit for the three months ended in Sep. 2014 was $0.00 Mil. ProText Mobility's Revenue for the three months ended in Sep. 2014 was $0.00 Mil. Therefore, ProText Mobility's Gross Margin % for the quarter that ended in Sep. 2014 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for ProText Mobility's Gross Margin % or its related term are showing as below:


TXTM's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 60.92
* Ranked among companies with meaningful Gross Margin % only.

ProText Mobility had a gross margin of N/A% for the quarter that ended in Sep. 2014 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for ProText Mobility was 0.00% per year.


ProText Mobility  (OTCPK:TXTM) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

ProText Mobility had a gross margin of N/A% for the quarter that ended in Sep. 2014 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


ProText Mobility Gross Margin % Related Terms


ProText Mobility Gross Margin % Historical Data

* Premium members only.

The historical data trend for ProText Mobility's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProText Mobility Gross Margin % Chart

ProText Mobility Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -164.52 -745.16 -280.77 -1,554.55 0.00

ProText Mobility Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TXTM vs DRSV, YPPN, CYBF: Gross Margin % Comparison

For the Biotechnology subindustry, ProText Mobility's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ProText Mobility Gross Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProText Mobility's Gross Margin % distribution charts can be found below:

* The bar in red indicates where ProText Mobility's Gross Margin % falls into.



ProText Mobility Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

ProText Mobility's Gross Margin for the fiscal year that ended in Dec. 2013 is calculated as

Gross Margin % (A: Dec. 2013 )=Gross Profit (A: Dec. 2013 ) / Revenue (A: Dec. 2013 )
=0 / 0.001
=(Revenue - Cost of Goods Sold) / Revenue
=(0.001 - 0) / 0.001
=N/A %

ProText Mobility's Gross Margin for the quarter that ended in Sep. 2014 is calculated as


Gross Margin % (Q: Sep. 2014 )=Gross Profit (Q: Sep. 2014 ) / Revenue (Q: Sep. 2014 )
=0 / 0.001
=(Revenue - Cost of Goods Sold) / Revenue
=(0.001 - 0) / 0.001
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 0.00% mean?
ProText Mobility (TXTM) has a Gross Margin % of 0.00% as of Sep. 2014. Gross margin is the ratio of total gross profit to net sales. View historical data on ProText Mobility and its competitors.
Is ProText Mobility's Gross Margin % too high?
ProText Mobility's current Gross Margin % is 0.00%.
How does ProText Mobility's Gross Margin % compare to DRSV and YPPN?
ProText Mobility's Gross Margin % of 0.00% can be compared against companies in the Biotechnology industry. The industry median Gross Margin % is 60.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.92, based on 737 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on ProText Mobility and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ProText Mobility's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ProText Mobility stock overvalued right now?
ProText Mobility (TXTM) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For ProText Mobility (TXTM), the current Gross Margin % is 0.00% as of Sep. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ProText Mobility Business Description

Address One West Las Olas Boulevard, Suite 500, Fort Lauderdale, FL, USA, 33301
ProText Mobility Inc is a Biotech Company developing a Hemp/CBD-Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes and technologies. Protext has engaged in the research, testing, and development of bioavailable botanical products, all-natural ingredients formulated for nutraceuticals and pharmaceutical applications through proprietary live plant extraction technology.